A short update on cancer chemoresistance

作者: Gerhard Hamilton , Barbara Rath

DOI: 10.1007/S10354-014-0311-Z

关键词:

摘要: Chemotherapeutic interventions in cancer patients are limited by the appearance of chemoresistance. For instance, advanced lung and ovarian relapse invariably after few cycles platinum-based chemotherapy. Disseminated tumors characterized genetic instability/heterogeneity, thus containing or generating a repertoire resistant subpopulations. At cellular level, altered drug uptake, efflux, metabolization, as well modifications targets, increased repair, decreased cell death complement perfusion adverse hypoxic/acidic extracellular conditions at tumor level retaining viability. Similarly, targeted therapy is rendered ineffective mutations specific target protein within months years administration. Assessment expression profiles cells revealed extensive changes numerous pathways affecting hundreds genes. Therefore, reversal resistance will require individual mediators combination several drugs, targeting critical components to provide new therapeutic options.

参考文章(57)
Philipp le Coutre, Elena Tassi, Marileila Varella-Garcia, Rossella Barni, Luca Mologni, Gonçalo Cabrita, Edoardo Marchesi, Rosanna Supino, Carlo Gambacorti-Passerini, Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood. ,vol. 95, pp. 1758- 1766 ,(2000) , 10.1182/BLOOD.V95.5.1758.005A41_1758_1766
Stefania Nobili, Ida Landini, Teresita Mazzei, Enrico Mini, Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression Medicinal Research Reviews. ,vol. 32, pp. 1220- 1262 ,(2012) , 10.1002/MED.20239
Hsing-Pang Lu, CC Chao, None, Cancer cells acquire resistance to anticancer drugs: An update Biomedical journal. ,vol. 35, pp. 464- 472 ,(2012) , 10.4103/2319-4170.104411
Karol Sikora, Giuseppe Giaccone, Herbert M. Pinedo, Comprar Drug Resistance in the Treatment of Cancer | Herbert M. Pinedo | 9780521030748 | Cambridge University Press Cambridge University Press. ,(2007)
Gerhart Kurz, Karin Barnouin, Inka Leier, Dietrich Keppler, Ulrike Buchholz, Gabriele Jedlitschky, Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Research. ,vol. 56, pp. 988- 994 ,(1996)
Wj Sluiter, Gj Meersma, H Timmerbosscha, Ege Devries, C Meijer, Nh Mulder, Relationship of Cellular Glutathione to the Cytotoxicity and Resistance of Seven Platinum Compounds Cancer Research. ,vol. 52, pp. 6885- 6889 ,(1992)
S. Kelley, A Basu, B. Teicher, M. Hacker, D. Hamer, J. Lazo, Overexpression of metallothionein confers resistance to anticancer drugs. Science. ,vol. 241, pp. 1813- 1815 ,(1988) , 10.1126/SCIENCE.3175622
U R Sorg, S Seeber, T Moritz, M Flasshove, W Bardenheuer, K Lehmberg, I Rattmann, A Brueckner, A Schneider, Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells. Leukemia. ,vol. 19, pp. 2281- 2288 ,(2005) , 10.1038/SJ.LEU.2403977
Valentina Fodale, Mariaelena Pierobon, Lance Liotta, Emanuel Petricoin, Mechanism of Cell Adaptation The Cancer Journal. ,vol. 17, pp. 89- 95 ,(2011) , 10.1097/PPO.0B013E318212DD3D
K. Nooter, G. Stoter, Molecular mechanisms of multidrug resistance in cancer chemotherapy Pathology Research and Practice. ,vol. 192, pp. 768- 780 ,(1996) , 10.1016/S0344-0338(96)80099-9